What is the differential diagnosis for a lymphoma positive for CD30 (Cluster of Differentiation 30) and CD15 (Cluster of Differentiation 15), negative for CD45 (Cluster of Differentiation 45), with presence of Reed-Sternberg cells?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differential Diagnosis for Lymphoma with Specific Immunophenotype

The presence of Reed-Sternberg cells along with a specific immunophenotype (CD30 and CD15 positive, CD45 negative) guides the differential diagnosis. Here's the organized differential diagnosis:

  • Single Most Likely Diagnosis

    • Hodgkin Lymphoma (HL), Classical Type: This is the most likely diagnosis given the presence of Reed-Sternberg cells and the specific immunophenotypic profile (CD30 and CD15 positive, CD45 negative). These markers are characteristic of classical Hodgkin lymphoma, particularly the nodular sclerosis subtype.
  • Other Likely Diagnoses

    • Anaplastic Large Cell Lymphoma (ALCL): Although less likely than classical HL due to the presence of Reed-Sternberg cells, ALCL can also be CD30 positive. However, it typically lacks Reed-Sternberg cells and has a different clinical presentation and prognosis.
    • Lymphocyte-Predominant Hodgkin Lymphoma (LPHL): This subtype of HL is less likely given the immunophenotype, as LPHL typically expresses CD20 and lacks CD15 and CD30 expression on the lymphocytic and histiocytic (L&H) cells, also known as "popcorn" cells.
  • Do Not Miss Diagnoses

    • Grey Zone Lymphoma: This is a rare and aggressive lymphoma that shares features of both classical Hodgkin lymphoma and diffuse large B-cell lymphoma. It can have a similar immunophenotype to classical HL but often has a more aggressive clinical course.
    • Primary Mediastinal Large B-Cell Lymphoma: Although typically CD20 positive and CD30 variable, this diagnosis is crucial not to miss due to its distinct clinical presentation and potential for aggressive behavior.
  • Rare Diagnoses

    • Non-Hodgkin Lymphoma with Reed-Sternberg-like Cells: Some non-Hodgkin lymphomas can rarely contain Reed-Sternberg-like cells, but these would not typically have the characteristic immunophenotype of classical HL.
    • Metastatic Carcinoma: Very rarely, metastatic carcinomas can mimic lymphomas, including expressing CD30, but this would be extremely unusual and other clinical and pathological features would not support this diagnosis.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.